Nursing home residents overlooked in COVID-19 antibody treatments

Of the 3.2 million doses of monoclonal antibody treatments for COVID-19 distributed across the U.S., only 13,500 doses have gone to nursing homes, NBC News reported Oct. 31. 

Advertisement

Health officials have had difficulty obtaining doses following a federal change limiting distribution.

States have been sending most doses of the monoclonal antibody treatments to hospitals and acute care centers, according to NBC News. 

Some states, however, have worked to ensure that long-term care facilities have access to the treatment. Minnesota officials utilize a policy prioritizing residents of nursing facilities through a weighted lottery. Emergency medical technicians and paramedics were directed to the Ascension Borgess Hospital system in Kalamazoo, Mich., to help administer doses following outbreaks at two centers.

In an Oct. 20 letter to White House policy adviser Amy Chang, advocates for long-term care called for a coordinated federal approach to ensure access to treatments. 

Neither HHS nor the White House has responded to the letter, NBC News reported.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Post-Acute

Advertisement

Comments are closed.